[Latest] Global mHealth Market Size/Share Worth USD 374.6 Billion by 2032 at a 17.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
March 14, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, March 14, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “mHealth Market Size, Trends and Insights By Device Type (Cardiac Monitors,...
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
March 13, 2024 09:00 ET
|
Femasys Inc.
-- CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment Options in Infertility Including FemaSeed® at 1PM ET...
[Latest] Global Smart Healthcare Products Market Size/Share Worth USD 485.71 Billion by 2032 at a 12.78% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
March 12, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, March 12, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Smart Healthcare Products Market Size, Trends and Insights By Type (Wearable...
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
March 06, 2024 09:00 ET
|
Femasys Inc.
-- Paving the way forward for the broader commercial availability of FemaSeed, an accessible, safe, and cost effective alternative to IVF -- -- Ongoing uncertainty following recent Alabama Supreme...
Analysis on China's $9+ Billion IVF Market, 2024-2030, Featuring Vitrolife, Cloudnine, Nova IVI Fertility, Monash IVF, Maria Fertility Hospital, Bangkok Fertility Center, and EMD Serono
March 01, 2024 10:41 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "China In-Vitro Fertilization Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report...
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
February 28, 2024 09:00 ET
|
Femasys Inc.
-- Femasys readies for the commercial launch of FemaSeed® in the U.S. amidst the uncertainty following the Alabama Supreme Court Ruling on how to handle embryos used for in vitro fertilization (IVF)...
GCC In-Vitro Fertilization (IVF) Market Report 2023-2033: Regional Growth Analysis by Procedure, End User & Product, Featuring Profiles of Prominent Market Players
January 30, 2024 09:29 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "GCC IVF Market: Focus on Procedure, End User, Product, and 8 Countries' Data - Analysis and Forecast, 2023-2033" report has been added to ...
Assisted Reproductive Technology Market Size to Exceed USD 58.6 billion by 2031, with a Robust CAGR of 9.4%| States Transparency Market Research, Inc.
January 08, 2024 06:02 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The assisted reproductive technology market was worth US$ 25.9 billion in 2022. By 2031,...
Preimplantation Genetic Testing Market is Expected to Reach $1.2 Billion | MarketsandMarkets.
December 18, 2023 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Preimplantation Genetic Testing market in terms of revenue was estimated to be worth $0.7 Billion in 2023 and is poised to reach $1.2 billion by 2028,...
Infertility Treatment Market is set to Reach US$ 3.14 billion at a CAGR of 7.90% from the forecast period 2023 to 2031 | Growth Plus Reports
December 13, 2023 00:48 ET
|
Growth Plus Reports
Pune, Dec. 13, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Infertility Treatment Market is expected to clock US$ 3.14 billion by 2031 and to...